Evolent Health, Inc. EVH Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.89B-21.3% | $1.88B-26.6% | $2.05B-16.6% | $2.2B-6.7% | $2.4B+10.2% | ||
| $1.51B-25.8% | $1.48B-32.5% | $1.68B-19.1% | $1.84B-4.2% | $2.03B+17.6% | ||
| $381.19M+4.2% | $399.88M+8.9% | $378.34M-3.8% | $359.26M-17.8% | $365.72M-18.2% | ||
| 20.2%+4.9pp | 21.3%+6.9pp | 18.4%+2.5pp | 16.4%-2.2pp | 15.2%-5.3pp | ||
| $298.28M+13.7% | $303.87M+15.5% | $278.91M-6.0% | $268.38M-17.7% | $262.36M-24.5% | ||
| $113.35M+0.4% | $115.85M-2.1% | $100.11M-15.6% | $106.2M-12.5% | $112.93M-8.7% | ||
| $2.31B-4.9% | $2.29B-11.9% | $2.07B-17.3% | $2.23B-6.9% | $2.43B+7.9% | ||
| -$419.12M-1,360% | -$410.14M-913% | -$20.5M+52.6% | -$37.66M+16.1% | -$28.7M+61.4% | ||
| -22.2%-21.0pp | -21.9%-20.3pp | -1%+0.8pp | -1.7%+0.2pp | -1.2%+2.2pp | ||
| $63.95M+120% | $57.47M+132% | $45.18M+49.4% | $34.72M-10.6% | $29.11M-38.5% | ||
| $3.93M-7.9% | $4.19M-24.4% | $4.15M-42.6% | $3.98M-47.0% | $4.27M-36.7% | ||
| $1.04M+462% | $249K+3.3% | $378K+205% | $255K+165% | $185K+159% | ||
| $373K+109% | $365K+110% | $334K+109% | -$2.05M-201% | -$3.95M-437% | ||
| -$497.21M-354% | -$534.64M-748% | -$127.75M-46.5% | -$131.55M-39.5% | -$109.47M+16.4% | ||
| -$686K-35.0% | -$126K+91.1% | $430K+103% | -$1.1M+94.5% | -$508K+97.5% | ||
| -$496.52M-356% | -$534.51M-767% | -$128.18M-77.5% | -$130.45M-75.3% | -$108.96M+1.2% | ||
| -26.3%-21.7pp | -28.5%-26.1pp | -6.2%-3.3pp | -5.9%-2.8pp | -4.5%+0.5pp | ||
| $37.26M+18.2% | $44.89M+41.0% | $52.7M+64.7% | $54.73M+72.2% | $31.52M+2.0% | ||
| -$4.76-287% | -$5.15-528% | -$1.58-73.6% | -$1.61-71.3% | -$1.23+1.6% | ||
| -$4.76-287% | -$5.15-528% | -$1.58-73.6% | -$1.61-71.3% | -$1.23+1.6% | ||
| 456.1M-0.8% | 459.5M+0.2% | 459.9M+1.1% | 460.7M+1.9% | 459.5M+2.4% | ||
| 456.1M-0.8% | 459.5M+0.2% | 459.9M+1.1% | 460.7M+1.9% | 459.5M+2.4% | ||
| $6.78M— | $6.5M— | —— | —— | —— | ||
| -$535.68M-280% | -$580.27M-518% | -$181.89M-74.3% | -$185.54M-74.3% | -$140.9M+0.4% | ||
| -$196K+99.6% | -$52.54M— | -$52.54M— | -$52.54M— | -$52.35M— | ||
| —— | $14.87M— | $11.15M+650% | $7.43M+283% | $3.72M+161% | ||
| $1.23M+106% | -$676K+96.4% | -$19.6M— | -$20.83M— | -$20.83M— | ||
| $1.04M+462% | $249K+3.3% | $378K+205% | $255K+165% | $185K+159% | ||
| $37.26M+18.2% | $44.89M+41.0% | $52.7M+64.7% | $54.73M+72.2% | $31.52M+2.0% | ||
| $1.89B-21.3% | $1.88B-26.6% | $2.05B-16.6% | $2.2B-6.7% | $2.4B+10.2% | ||
| -$419.12M-1,360% | -$410.14M-913% | -$20.5M+52.6% | -$37.66M+16.1% | -$28.7M+61.4% | ||
| -$305.77M-463% | -$294.29M-478% | $79.61M+5.5% | $68.54M-10.4% | $84.23M+70.6% | ||
| -$305.77M-463% | -$294.29M-478% | $79.61M+5.5% | $68.54M-10.4% | $84.23M+70.6% | ||
| -16.2%-19.7pp | -15.7%-18.7pp | 3.9%+0.8pp | 3.1%-0.1pp | 3.5%+1.2pp | ||
| -$419.12M-1,360% | -$410.14M-913% | -$20.5M+52.6% | -$37.66M+16.1% | -$28.7M+61.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Evolent Health, Inc.'s revenue?
- Evolent Health, Inc. (EVH) generated $1.9B in revenue over the trailing twelve months, down 21.3% year over year.
- Is Evolent Health, Inc. profitable?
- Evolent Health, Inc. is not currently profitable: it reported a net loss of $496.5M over the trailing twelve months, a -26.3% net margin.
- What are Evolent Health, Inc.'s profit margins?
- Gross margin is 20.2% and operating margin is -22.2%, with a -26.3% net margin.
- What is Evolent Health, Inc.'s earnings per share?
- Evolent Health, Inc.'s diluted EPS over the trailing twelve months is $-4.76.
- Where does Evolent Health, Inc.'s income statement data come from?
- Every line is extracted from Evolent Health, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
